exploited the property of APOE to effectively cross the blood-brain barrier in vitro to reveal APOE-mediated whole-body nano-delivery of granzyme B and CpG for the enhancement of glioma immunotherapy. The gene discussed is GZMB; the disease is central nervous system cancer.